Invasive Aspergillosis [clinicaltrials_resource:c65b7c3f583a3f8975ba47ee6bc840df]
Study Safety/Efficacy of AmBisome Loading Dose Regimen Versus Standard AmBisome Regimen for Initial Treatment [clinicaltrials:NCT00158730]A Multicentre Randomised Controlled Trial Comparing Two Strategies for the Diagnosis of Invasive Aspergillosis in High-risk Haematology Patients [clinicaltrials:NCT00163722]COMBISTRAT: AmBisome® in Combination With Caspofungin for the Treatment of Invasive Aspergillosis [clinicaltrials:NCT00334412]clinicaltrials:NCT00376337clinicaltrials:NCT00404092Diagnostic and Management Strategies for Invasive Aspergillosis [clinicaltrials:NCT00816088]clinicaltrials:NCT00836875Invasive Aspergillosis After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) [clinicaltrials:NCT00838643]Surveillance for Nosocomial Infections in Pediatric Cancer Patients [clinicaltrials:NCT00843804]Validation of an Index of Neutropenia (D-index) in Febrile Neutropenic Cancer Patients [clinicaltrials:NCT00982540]Influence of Drug-drug Interactions on the Pharmacokinetics (PK) of Voriconazole [clinicaltrials:NCT01080651]Galactomannan Antigen in Bronchoalveolar Lavage in the Diagnosis of Invasive Aspergillosis in Neutropenic Patients [clinicaltrials:NCT01128907]Correlation Between Circulating Galactomannan and Beta-D-glucan and Clinical Outcome of Invasive Aspergillosis [clinicaltrials:NCT01176071]Diagnosing Pulmonary Aspergillosis in Patients With Hematological Malignancies: A Multicentre Prospective Evaluation of an Aspergillus PCR Assay and a Galactomannan ELISA in Bronchoalveolar Lavage Samples [clinicaltrials:NCT01430663]Diagnosing Invasive Aspergillosis by Polymerase Chain Reaction (PCR) Based Investigation of Bronchoalveolar Lavage Samples During Antifungal Therapy [clinicaltrials:NCT01448226]clinicaltrials:NCT01695512clinicaltrials:NCT02104479clinicaltrials:NCT02106117clinicaltrials:NCT02142153F901318 Multiple Ascending Dose Study [clinicaltrials:NCT02342574]Single Ascending Oral Dose Study of F901318 [clinicaltrials:NCT02394483]Concentrations of Voriconazole in Blood and BAL-fluid After Inhalation and Oral Administration [clinicaltrials:NCT02396225]
condition [clinicaltrials_vocabulary:condition]
Invasive Aspergillosis [clinicaltrials_resource:c65b7c3f583a3f8975ba47ee6bc840df]
Bio2RDF identifier
c65b7c3f583a3f8975ba47ee6bc840df
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:c65b7c3f583a3f8975ba47ee6bc840df
identifier
clinicaltrials_resource:c65b7c3f583a3f8975ba47ee6bc840df
title
Invasive Aspergillosis
@en
label
Invasive Aspergillosis [clinicaltrials_resource:c65b7c3f583a3f8975ba47ee6bc840df]
@en